These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 18387797)
1. Effect of disease duration on dose-response of inhaled budesonide in asthma. Selroos O Respir Med; 2008 Jul; 102(7):1065-72. PubMed ID: 18387797 [TBL] [Abstract][Full Text] [Related]
2. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. Evans DJ; Taylor DA; Zetterstrom O; Chung KF; O'Connor BJ; Barnes PJ N Engl J Med; 1997 Nov; 337(20):1412-8. PubMed ID: 9358138 [TBL] [Abstract][Full Text] [Related]
3. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler. Murphy K; Noonan M; Silkoff PE; Uryniak T Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of budesonide Clickhaler and Turbuhaler in adult asthma. Morice A; Das S; Ellis S; J Asthma; 2005 Oct; 42(8):697-703. PubMed ID: 16266962 [TBL] [Abstract][Full Text] [Related]
5. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma. Banov CH; Howland WC; Lumry WR Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734 [TBL] [Abstract][Full Text] [Related]
6. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989 [TBL] [Abstract][Full Text] [Related]
7. Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma. Tukiainen H; Taivainen A; Majander R; Poussa T; Svahn T; Puolijoki H; Terho EO Respir Med; 2000 Jul; 94(7):678-83. PubMed ID: 10926339 [TBL] [Abstract][Full Text] [Related]
8. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment. Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752 [TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of budesonide inhalation suspension: a nebulizable corticosteroid for persistent asthma in infants and young children. White MV; Cruz-Rivera M; Walton-Bowen K Fam Med; 1999 May; 31(5):337-45. PubMed ID: 10407712 [TBL] [Abstract][Full Text] [Related]
10. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. Busse WW; Pedersen S; Pauwels RA; Tan WC; Chen YZ; Lamm CJ; O'Byrne PM; J Allergy Clin Immunol; 2008 May; 121(5):1167-74. PubMed ID: 18405951 [TBL] [Abstract][Full Text] [Related]
11. Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial. Chen YZ; Busse WW; Pedersen S; Tan W; Lamm CJ; O'Byrne PM Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():7-13. PubMed ID: 16573703 [TBL] [Abstract][Full Text] [Related]
12. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. Busse WW; Chervinsky P; Condemi J; Lumry WR; Petty TL; Rennard S; Townley RG J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):457-63. PubMed ID: 9564797 [TBL] [Abstract][Full Text] [Related]
13. Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge. Lipworth BJ; Sims EJ; Das SK; Buck H; Paterson M Ann Allergy Asthma Immunol; 2005 Jun; 94(6):675-81. PubMed ID: 15984601 [TBL] [Abstract][Full Text] [Related]
14. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. Haahtela T; Järvinen M; Kava T; Kiviranta K; Koskinen S; Lehtonen K; Nikander K; Persson T; Selroos O; Sovijärvi A N Engl J Med; 1994 Sep; 331(11):700-5. PubMed ID: 8058076 [TBL] [Abstract][Full Text] [Related]
15. Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma. Haahtela T; Tamminen K; Kava T; Malmberg LP; Rytilä P; Nikander K; Persson T; Selroos O J Allergy Clin Immunol; 2009 Dec; 124(6):1180-5. PubMed ID: 20004779 [TBL] [Abstract][Full Text] [Related]
16. A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma. Ige OM; Sogaolu OM Afr J Med Med Sci; 2004 Jun; 33(2):155-60. PubMed ID: 15565935 [TBL] [Abstract][Full Text] [Related]
17. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma. Boulet LP; Turcotte H; Prince P; Lemière C; Olivenstein R; Laprise C; Larivée P; Bégin P; Laviolette M Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221 [TBL] [Abstract][Full Text] [Related]
19. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme. den Otter JJ; van Schayck CP; Folgering HT; van den Boom G; Akkermans RP; van Weel C Eur J Gen Pract; 2007; 13(2):89-91. PubMed ID: 17534745 [TBL] [Abstract][Full Text] [Related]